FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Enrica Martinelli

Research Profile

Disorders

Procedures

Chemicals & Drugs

Physiology

Concepts & Ideas

Anatomy

Tumor Cell Line

Co-author Network

Publications

TOP 3
Silvia Prislei; Giuseppina Raspaglio; Giovanni Scambia; Shohreh Shahabi; Steven Sieber; Gabriella Ferrandina; Marisa Mariani; Enrica Martinelli; Ferlini Cristiano
MiR-200c and HuR in ovarian cancer.
Simona Mozzetti; Silvia Prislei; Giuseppina Raspaglio; Giovanni Scambia; Shohreh Shahabi; Marta De Donato; Flavia Filippetti; Enrica Martinelli; Ferlini Cristiano
Gli family transcription factors are drivers of patupilone resistance in ovarian cancer.
Marisa Mariani; Enrica Martinelli; Candice Martino; Giovanni Scambia; Shohreh Shahabi; Steven Sieber; Stefano Sioletic; Gian Franco Zannoni; Claudio Coco; Ferlini Cristiano
Gender influences the class III and V β-tubulin ability to predict poor outcome in colorectal cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Enrica Martinelli (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Silvia Prislei; Giuseppina Raspaglio; Giovanni Scambia; Shohreh Shahabi; Steven Sieber; Gabriella Ferrandina; Marisa Mariani; Enrica Martinelli; Ferlini Cristiano
MiR-200c and HuR in ovarian cancer.
BMC cancer 2013;13():72.
2012: Simona Mozzetti; Silvia Prislei; Giuseppina Raspaglio; Giovanni Scambia; Shohreh Shahabi; Marta De Donato; Flavia Filippetti; Enrica Martinelli; Ferlini Cristiano
Gli family transcription factors are drivers of patupilone resistance in ovarian cancer.
Biochemical pharmacology 2012;84(11):1409-18.
2012: Marisa Mariani; Enrica Martinelli; Candice Martino; Giovanni Scambia; Shohreh Shahabi; Steven Sieber; Stefano Sioletic; Gian Franco Zannoni; Claudio Coco; Ferlini Cristiano
Gender influences the class III and V β-tubulin ability to predict poor outcome in colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(10):2964-75.
2012: Marta De Donato; Gabriella Ferrandina; Marisa Mariani; Enrica Martinelli; Lella Petrella; Giovanni Scambia; Shohreh Shahabi; Valerio Gaetano Vellone; Gian Franco Zannoni; Ferlini Cristiano
Class III β-tubulin and the cytoskeletal gateway for drug resistance in ovarian cancer.
Journal of cellular physiology 2012;227(3):1034-41.
2010: Giuseppina Raspaglio; Ilaria De Maria; Flavia Filippetti; Enrica Martinelli; Gian Franco Zannoni; Silvia Prislei; Gabriella Ferrandina; Shohreh Shahabi; Giovanni Scambia; Ferlini Cristiano
HuR regulates beta-tubulin isotype expression in ovarian cancer.
Cancer research 2010;70(14):5891-900.
2010: Alessandra Battaglia; Alexia Buzzonetti; Enrica Martinelli; Mara Fanelli; Marco Petrillo; Gabriella Ferrandina; Giovanni Scambia; Andrea Fattorossi
Selective changes in the immune profile of tumor-draining lymph nodes after different neoadjuvant chemoradiation regimens for locally advanced cervical cancer.
International journal of radiation oncology, biology, physics 2010;76(5):1546-53.
2010: Daniela Meco; Tiziana Servidei; Gian Franco Zannoni; Enrica Martinelli; Maria Grazia Prisco; C De Waure; Riccardo Riccardi
Dual Inhibitor AEE788 Reduces Tumor Growth in Preclinical Models of Medulloblastoma.
Translational oncology 2010;3(5):326-35.
2009: Alessandra Battaglia; Alexia Buzzonetti; Cinzia Baranello; Gabriella Ferrandina; Enrica Martinelli; Francesco Fanfani; Giovanni Scambia; Andrea Fattorossi
Metastatic tumour cells favour the generation of a tolerogenic milieu in tumour draining lymph node in patients with early cervical cancer.
Cancer immunology, immunotherapy : CII 2009;58(9):1363-73.
2009: Fiorella Miceli; Franco O Ranelletti; Enrica Martinelli; Marco Petrillo; Giovanni Scambia; Pierluigi Navarra; Gabriella Ferrandina
Expression and subcellular localization of CRH and its receptors in human endometrial cancer.
Molecular and cellular endocrinology 2009;305(1-2):6-11.
2008: Gabriella Ferrandina; Enrica Martinelli; Marco Petrillo; Maria Grazia Prisco; Adriana Zucconi; Salvatore Santaguida; Gian Franco Zannoni; Giovanni Scambia; Ferlini Cristiano
Prognostic role of the recepteur d'origine nantais (RON) expression in ovarian cancer patients.
Gynecologic oncology 2008;111(2):237-43.
2008: Gabriella Ferrandina; M Petrillo; A Carbone; Gian Franco Zannoni; Enrica Martinelli; M Prisco; Sandro Pignata; Enrico Breda; A Savarese; Giovanni Scambia
Prognostic role of topoisomerase-IIalpha in advanced ovarian cancer patients.
British journal of cancer 2008;98(12):1910-5.
2007: Gabriella Ferrandina; Arnaldo Carbone; Gian Franco Zannoni; Enrica Martinelli; Antonia Carla Testa; Valerio Gallotta; Maria De Ninno; Giovanni Scambia
Serous ovarian carcinoma recurring as a heterologous carcinosarcoma.
The journal of obstetrics and gynaecology research 2007;33(1):95-9.
2007: Gabriella Ferrandina; Enrica Martinelli; Gian Franco Zannoni; Mariagrazia Distefano; Amelia Paglia; Ferlini Cristiano; Giovanni Scambia
Expression of class III beta tubulin in cervical cancer patients administered preoperative radiochemotherapy: correlation with response to treatment and clinical outcome.
Gynecologic oncology 2007;104(2):326-30.
2007: Gabriella Ferrandina; Gian Franco Zannoni; Enrica Martinelli; Valerio Gaetano Vellone; M G Prisco; Giovanni Scambia
Endometrial carcinoma recurring as carcinosarcoma: report of two cases.
Pathology, research and practice 2007;203(9):677-81.
2007: Gabriella Ferrandina; Gian Franco Zannoni; Marco Petrillo; Valerio Gaetano Vellone; Enrica Martinelli; Giovanni Scambia
Glassy cell carcinoma of the endometrium: a case report and review of the literature.
Pathology, research and practice 2007;203(4):217-20.
2006: Gabriella Ferrandina; Gian Franco Zannoni; Enrica Martinelli; Amelia Paglia; Valerio Gallotta; Simona Mozzetti; Giovanni Scambia; Ferlini Cristiano
Class III beta-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(9):2774-9.
2006: Gabriella Ferrandina; Franco O Ranelletti; Francesco Legge; Vanda Salutari; Enrica Martinelli; Andrea Fattorossi; Domenica Lorusso; Gian Franco Zannoni; Valerio Gaetano Vellone; Amelia Paglia; Giovanni Scambia
Celecoxib up-regulates the expression of the zeta chain of T cell receptor complex in tumor-infiltrating lymphocytes in human cervical cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(7 Pt 1):2055-60.
2006: Gabriella Ferrandina; Franco O Ranelletti; Enrica Martinelli; Amelia Paglia; Gian Franco Zannoni; Giovanni Scambia
Cyclo-oxygenase-2 (Cox-2) expression and resistance to platinum versus platinum/paclitaxel containing chemotherapy in advanced ovarian cancer.
BMC cancer 2006;6():182.
2006: Daniela Gallo; Gian Franco Zannoni; Enrica Martinelli; Ferlini Cristiano; Manuela Fabrizi; Antonella Riva; Paolo Morazzoni; Ezio Bombardelli; Giovanni Scambia
Estradiol and phytoestrogens differently influence the rodent postmenopausal mammary gland.
Menopause (New York, N.Y.) 2006;13(1):72-9.
2005: Daniela Gallo; Gian Franco Zannoni; Patrizia Apollonio; Enrica Martinelli; Ferlini Cristiano; Gianluigi Passetti; Antonella Riva; Paolo Morazzoni; Ezio Bombardelli; Giovanni Scambia
Characterization of the pharmacologic profile of a standardized soy extract in the ovariectomized rat model of menopause: effects on bone, uterus, and lipid profile.
Menopause (New York, N.Y.) 2005;12(5):589-600.
2005: Gabriella Ferrandina; Franco O Ranelletti; Valerio Gallotta; Enrica Martinelli; Gian Franco Zannoni; Marco Gessi; Giovanni Scambia
Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer.
Gynecologic oncology 2005;98(3):383-9.
2005: Gabriella Ferrandina; Francesco Legge; Enrica Martinelli; Franco O Ranelletti; Gian Franco Zannoni; Libero Lauriola; Marco Gessi; Valerio Gallotta; Giovanni Scambia
Survivin expression in ovarian cancer and its correlation with clinico-pathological, surgical and apoptosis-related parameters.
British journal of cancer 2005;92(2):271-7.
2005: Simona Mozzetti; Ferlini Cristiano; Paola Concolino; Flavia Filippetti; Giuseppina Raspaglio; Silvia Prislei; Daniela Gallo; Enrica Martinelli; Franco O Ranelletti; Gabriella Ferrandina; Giovanni Scambia
Class III beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(1):298-305.
2004: Paola Concolino; Valerio Papa; Simona Mozzetti; Ferlini Cristiano; Fabio Pacelli; Enrica Martinelli; Riccardo Ricci; Flavia Filippetti; Giovanni Scambia; Giovanni Battista Doglietto
The unsolved enigma of CDH1 down-regulation in hereditary diffuse gastric cancer.
The Journal of surgical research 2004;121(1):50-5.
2004: Gabriella Ferrandina; Franco O Ranelletti; Francesco Legge; Marco Gessi; Vanda Salutari; Mariagrazia Distefano; Libero Lauriola; Gian Franco Zannoni; Enrica Martinelli; Giovanni Scambia
Prognostic role of the ratio between cyclooxygenase-2 in tumor and stroma compartments in cervical cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(9):3117-23.
2003: Ferlini Cristiano; Giuseppina Raspaglio; Simona Mozzetti; Mariagrazia Distefano; Flavia Filippetti; Enrica Martinelli; Gabriella Ferrandina; Daniela Gallo; Franco O Ranelletti; Giovanni Scambia
Bcl-2 down-regulation is a novel mechanism of paclitaxel resistance.
Molecular pharmacology 2003;64(1):51-8.